SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001367920-18-000024
Filing Date
2018-05-03
Accepted
2018-05-03 07:37:17
Documents
4
Period of Report
2018-06-14
Effectiveness Date
2018-05-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2018proxy.htm DEF 14A 605433
2 a2018proxycard1.jpg GRAPHIC 243242
3 a2018proxycard2.jpg GRAPHIC 199880
4 cncelogo.jpg GRAPHIC 11456
  Complete submission text file 0001367920-18-000024.txt   1232594
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36310 | Film No.: 18801816
SIC: 2834 Pharmaceutical Preparations